Cathie Wood's ARK Innovation ETF is back — and back big. It's the top diversified ETF again this year so far, largely due to big winners.
PLEASANTON, Calif. , Jan. 19, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after market
Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.
This segment originally aired on January 10, 2023. 10x Genomics CEO Serge Saxonov joins Yahoo Finance live anchor Rachell Akuffo to discuss biotechnology innovation, progress in genomics, and macroeco
PLEASANTON, Calif. , Dec. 28, 2022  /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be
10x Genomics is targeting larger addressable market opportunities over the mid to long term. The accelerated Xenium launch will bolster the growth potential but may be insufficient to plug a looming s
The stock market witnessed an upward trend last month, a continuation from October.
Torex Gold Resources Inc. (OTCPK:TORXF) Q3 2022 Earnings Conference Call November 10, 2022 9:00 AM ET Company Participants Dan Rollins - Senior Vice President, Corporate Development & Investor Relatio
10x Genomics, Inc. (NASDAQ:TXG ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Cassie Corneau - Head, Investor Relations & Strategic Finance Serge Saxonov - Chief E
10x Genomics (TXG) delivered earnings and revenue surprises of 17.78% and 1.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 Boring Stocks with Exciting Profit Potential

09:17am, Thursday, 27'th Oct 2022
There's nothing wrong with holding a portfolio consisting of boring stocks. You know, the kind of steady blue-chip stocks that don't necessarily perform as well in a bull market but hold steady in a b
PLEASANTON, Calif. , Oct. 12, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2022 after market close on Wednesday, November 2,
Their long-term plans are ambitious, but they haven't performed well as investments recently.
The best performer on this list has lost three-fourths of its value this year.
PLEASANTON, Calif. , Sept. 2, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be pa
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE